Sec-O-Glucosylhamaudol
Sec-O-Glucosylhamaudol exhibits anti-inflammatory activity in LPS-stimulated RAW264.7 macrophages by modulating p38 MAPK signaling. In vivo studies, such as the formalin test, demonstrate its potent, opioid receptor-mediated antinociceptive effects following intrathecal administration, supporting research in neuropharmacology and inflammation.
Product Specifications
CAS Number
80681-44-3
Product Name Alternative
SecOGlucosylhamaudol, Sec-O-Glucosylhamaudol, Sec O Glucosylhamaudol, OpioidReceptor, Opioid Receptor, inhibit, Hamaudol 3-glucoside, Inhibitor
Field of Research
Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Purity
99.35% (May vary between batches)
Solubility
Ethanol:Soluble; Pyridine, Methanol, etc.:Soluble;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.53 mM) ; DMSO:80 mg/mL (182.47 mM)
Smiles
Cc1cc (=O) c2c (O) c3C[C@H] (O[C@@H]4O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@H]4O) C (C) (C) Oc3cc2o1
Molecular Formula
C21H26O10
Molecular Weight
438.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-ERBB1 / EGFR / HER1 Reference Antibody (panitumumab)
Recombinant Rat FBXO17 Protein, His (Fc)-Avi-tagged